BMC Research Notes (Dec 2022)

Impact of blood perilipin A levels on obesity and metabolic health

  • Emmanuel K. Ofori,
  • Bright Selorm Letsu,
  • Seth K. Amponsah,
  • John Ahenkorah,
  • Sandra Crabbe,
  • Genevieve Kwao-Zigah,
  • Sylvester Y. Oppong,
  • Patrick Diaba-Nuhoho,
  • Seth D. Amanquah

DOI
https://doi.org/10.1186/s13104-022-06261-3
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Objective Perilipin A is a common protein that coats lipid surfaces preventing them from being exposed to oxidative damage. Researchers have found little consistency in the relationship between perilipin A levels in the blood and body fat. This study was a cross-sectional observational that looked at circulating perilipin A levels and how they relate to metabolic health. Results The participants in this study were 86 individuals with a mean age of 45.5 ± 1.2 years. Multiple clinical and metabolic indicators (age, weight, BMI, total body fat mass, triglyceride, and HOMA-IR) were shown to be inversely associated with perilipin A levels (rho = − 0.32, − 0.37, − 0.40, − 0.45, − 0.33 and − 0.29; p < 0.05 respectively). Obese persons were almost six times more likely than non-obese individuals to have lower perilipin A levels (odds ratio = 6.22, CI = 2.35–11.50, p < 0.001). Our findings underscore the important role of perilipin A proteins in metabolic health.

Keywords